Canagliflozin: a New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y-gastric By-pass
Latest Information Update: 05 Jan 2023
At a glance
- Drugs Canagliflozin (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- Acronyms CANA-PHH-RYGB
- 27 Jan 2021 New trial record